Rockwell Medical Stock Rating Reaffirmed by Craig Hallum (RMTI)
Rockwell Medical (NASDAQ:RMTI)‘s stock had its “buy” rating reaffirmed by equities research analysts at Craig Hallum in a research note issued to investors on Friday, Analyst Ratings Network.com reports. They currently have a $16.00 target price on the stock. Craig Hallum’s target price indicates a potential upside of 48.56% from the company’s current price.
Several other analysts have also recently commented on the stock. Analysts at Stifel Nicolaus raised their price target on shares of Rockwell Medical (NASDAQ:RMTI) to $18.00 in a research note to investors on Friday. They now have a “hold” rating on the stock. Separately, analysts at Zacks upgraded shares of Rockwell Medical (NASDAQ:RMTI) from an “underperform” rating to a “neutral” rating in a research note to investors on Tuesday, September 17th. They now have a $10.50 price target on the stock. Finally, analysts at Summer Street raised their price target on shares of Rockwell Medical (NASDAQ:RMTI) from $20.00 to $25.00 in a research note to investors on Thursday, September 5th. They now have a “buy” rating on the stock. Two research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. The company presently has a consensus rating of “Buy” and an average price target of $16.08.
Shares of Rockwell Medical (NASDAQ:RMTI) traded up 16.94% during mid-day trading on Friday, hitting $10.77. The stock had a trading volume of 5,175,603 shares. Rockwell Medical has a 1-year low of $3.16 and a 1-year high of $11.80. The stock has a 50-day moving average of $7.22 and a 200-day moving average of $4.87. The company’s market cap is $429.9 million.
Rockwell Medical, Inc, formerly Rockwell Medical Technologies, Inc, manufactures hemodialysis concentrate solutions and dialysis kits, and it sells, distributes and delivers these and other ancillary hemodialysis products primarily to hemodialysis providers in the United States, as well as internationally primarily in Asia, Latin America and Europe.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.